Amiodarone

Active ingredient description

Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Amiodarone
C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD01

Medicines

Amiodarone is the active ingredient of these drugs:

Drug
Countries

Ecuador

Hong Kong

South Africa

Australia

South Africa

Brazil

Tunisia

Ecuador

Ecuador

Germany

Germany

Estonia Lithuania Poland

Brazil

South Africa

Brazil

Australia New Zealand

South Africa

South Africa

Brazil Ecuador

Brazil

Cyprus

Australia Ecuador Estonia Finland France

Singapore

South Africa

New Zealand

United States

Poland

United States

Tunisia

Australia

Austria Tunisia

Spain

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 645.312 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1951-25-3
CAS Substance: 19774-82-4
DrugBank Drug: DB01118
KEGG Drug: D02910
RxNorm Ingredient: 703
SNOMED-CT Concept: 372821002
Amiodarone (substance)
UNII Identifier: N3RQ532IUT
AMIODARONE